OVOL1/2 regulate trophectoderm differentiation during the morula-to-blastocyst transition
Related Experiment Video
Updated: Oct 31, 2026

Protocol for Human Blastoids Modeling Blastocyst Development and Implantation
Published on: August 10, 2022
Yi Zhu1,2, Xueqin Chen1, Xin Deng1
1NHC Key Laboratory of Human Stem Cell and Reproductive Engineering, Xiangya School of Basic Medical Sciences, Central South University, Changsha, China.
Abstract:
The blastocyst formation rate of human embryos cultured in vitro for assisted reproduction is approximately 50%, with most embryos arresting at the cleavage stage; however, the underlying mechanisms remain poorly understood. Here, we performed single-cell RNA sequencing of biopsied blastomeres from morphologically high-quality 8-cell embryos and tracked the developmental progression of the remaining embryos to the blastocyst stage. Embryos that failed to form blastocysts exhibited impaired zygotic genome activation (ZGA). We identified OVOL1/2 as critical ZGA genes that were markedly underactivated in these embryos. Functional analyses in both mouse and human embryos demonstrate that depletion of OVOL1/2 disrupts trophectoderm differentiation via ARPC1B-dependent mechanisms, thereby impairing the morula-to-blastocyst transition. Collectively, these findings provide mechanistic insights into preimplantation embryonic development and reveal potential causes of blastocyst formation failure.
Related Concept Videos
Cleavage and Blastulation
Zygotic Development And Stem Cell Formation
Cellular Differentiation
A zygote is a...
Gastrulation
Regulation of Angiogenesis and Blood Supply
Determination

